142 related articles for article (PubMed ID: 11262619)
1. Active drug targeting with immunoconjugates to choroidal neovascularization.
Yasukawa T; Kimura H; Tabata Y; Miyamoto H; Honda Y; Ikada Y; Ogura Y
Curr Eye Res; 2000 Dec; 21(6):952-61. PubMed ID: 11262619
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody-mediated drug targeting to choroidal neovascularization in the rat.
Kamizuru H; Kimura H; Yasukawa T; Tabata Y; Honda Y; Ogura Y
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2664-72. PubMed ID: 11581214
[TBL] [Abstract][Full Text] [Related]
3. Correlation of CD105 and vascular endothelial growth factor in laser-induced choroidal neovascularization in rats.
Xu J; Wang Y; Yang X; Zhang P; Chen L
Yan Ke Xue Bao; 2006 Sep; 22(3):166-74, 183. PubMed ID: 17162902
[TBL] [Abstract][Full Text] [Related]
4. [Experimental choroidal neovascularization is inhibited by subretinal administration of Endostatin].
Shang QL; Ma JX; Wei JS; Shang ZL; Xiu HM; Yang AQ
Zhonghua Yan Ke Za Zhi; 2004 Apr; 40(4):266-71. PubMed ID: 15268837
[TBL] [Abstract][Full Text] [Related]
5. Expression of endostatin in human choroidal neovascular membranes secondary to age-related macular degeneration.
Tatar O; Shinoda K; Adam A; Rohrbach JM; Lucke K; Henke-Fahle S; Bartz-Schmidt KU; Grisanti S
Exp Eye Res; 2006 Aug; 83(2):329-38. PubMed ID: 16584730
[TBL] [Abstract][Full Text] [Related]
6. Expression of VEGF and PEDF in choroidal neovascular membranes following verteporfin photodynamic therapy.
Tatar O; Adam A; Shinoda K; Stalmans P; Eckardt C; Lüke M; Bartz-Schmidt KU; Grisanti S
Am J Ophthalmol; 2006 Jul; 142(1):95-104. PubMed ID: 16815256
[TBL] [Abstract][Full Text] [Related]
7. Expression of endoglin in choroidal neovascularization.
Grisanti S; Canbek S; Kaiserling E; Adam A; Lafaut B; Gelisken F; Szurman P; Henke-Fahle S; Oficjalska-Mlynczak J; Bartz-Schmidt KU
Exp Eye Res; 2004 Feb; 78(2):207-13. PubMed ID: 14729353
[TBL] [Abstract][Full Text] [Related]
8. Drug targeting to choroidal neovascularization.
Kimura H; Yasukawa T; Tabata Y; Ogura Y
Adv Drug Deliv Rev; 2001 Oct; 52(1):79-91. PubMed ID: 11672877
[TBL] [Abstract][Full Text] [Related]
9. Soluble EphB4 regulates choroidal endothelial cell function and inhibits laser-induced choroidal neovascularization.
He S; Ding Y; Zhou J; Krasnoperov V; Zozulya S; Kumar SR; Ryan SJ; Gill PS; Hinton DR
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4772-9. PubMed ID: 16303978
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization.
Murata T; He S; Hangai M; Ishibashi T; Xi XP; Kim S; Hsueh WA; Ryan SJ; Law RE; Hinton DR
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2309-17. PubMed ID: 10892878
[TBL] [Abstract][Full Text] [Related]
11. Immunohistopathologic evaluation of choroidal neovascular membranes following verteporfin-photodynamic therapy.
Grisanti S; Tatar O; Canbek S; Lafaut BA; Gelisken F; Inhoffen W; Szurman P; Aisenbrey S; Oficjalska-Mlynczak J; Bartz-Schmidt KU
Am J Ophthalmol; 2004 May; 137(5):914-23. PubMed ID: 15126158
[TBL] [Abstract][Full Text] [Related]
12. Expression of vasohibin, an antiangiogenic factor, in human choroidal neovascular membranes.
Wakusawa R; Abe T; Sato H; Yoshida M; Kunikata H; Sato Y; Nishida K
Am J Ophthalmol; 2008 Aug; 146(2):235-243. PubMed ID: 18486097
[TBL] [Abstract][Full Text] [Related]
13. Angiography of fluoresceinated anti-vascular endothelial growth factor antibody and dextrans in experimental choroidal neovascularization.
Tolentino MJ; Husain D; Theodosiadis P; Gragoudas ES; Connolly E; Kahn J; Cleland J; Adamis AP; Cuthbertson A; Miller JW
Arch Ophthalmol; 2000 Jan; 118(1):78-84. PubMed ID: 10636419
[TBL] [Abstract][Full Text] [Related]
14. Influence of verteporfin photodynamic therapy on inflammation in human choroidal neovascular membranes secondary to age-related macular degeneration.
Tatar O; Adam A; Shinoda K; Yoeruek E; Szurman P; Bopp S; Eckardt C; Bartz-Schmidt KU; Grisanti S
Retina; 2007; 27(6):713-23. PubMed ID: 17621180
[TBL] [Abstract][Full Text] [Related]
15. Scavenger receptors for oxidized lipoprotein in age-related macular degeneration.
Kamei M; Yoneda K; Kume N; Suzuki M; Itabe H; Matsuda K; Shimaoka T; Minami M; Yonehara S; Kita T; Kinoshita S
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1801-7. PubMed ID: 17389514
[TBL] [Abstract][Full Text] [Related]
16. Topical application of a G-Quartet aptamer targeting nucleolin attenuates choroidal neovascularization in a model of age-related macular degeneration.
Leaderer D; Cashman SM; Kumar-Singh R
Exp Eye Res; 2015 Nov; 140():171-178. PubMed ID: 26368850
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of RACK1 ameliorates choroidal neovascularization formation in vitro and in vivo.
Liu X; Zhu M; Yang X; Wang Y; Qin B; Cui C; Chen H; Sang A
Exp Mol Pathol; 2016 Jun; 100(3):451-9. PubMed ID: 27112838
[TBL] [Abstract][Full Text] [Related]
18. Laser-induced choroidal neovascularization in mice attenuated by deficiency in the apelin-APJ system.
Hara C; Kasai A; Gomi F; Satooka T; Sakimoto S; Nakai K; Yoshioka Y; Yamamuro A; Maeda S; Nishida K
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4321-9. PubMed ID: 23722395
[TBL] [Abstract][Full Text] [Related]
19. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide.
Takahashi N; Haba A; Matsuno F; Seon BK
Cancer Res; 2001 Nov; 61(21):7846-54. PubMed ID: 11691802
[TBL] [Abstract][Full Text] [Related]
20. Synergy between anti-endoglin (CD105) monoclonal antibodies and TGF-beta in suppression of growth of human endothelial cells.
She X; Matsuno F; Harada N; Tsai H; Seon BK
Int J Cancer; 2004 Jan; 108(2):251-7. PubMed ID: 14639611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
